Please enable JavaScript to continue using this application.

Compare $RGEN vs $TECH | Chartloom

Compare

$RGEN vs $TECH

Repligen Corp · Bio-Techne Corp

RGEN

Repligen Corp

TECH

Bio-Techne Corp

Compare $RGEN vs $TECH

Comparing Repligen Corp and Bio-Techne Corp

RGENRepligen Corp

TECHBio-Techne Corp

RGENRepligen Corp

Market cap

$9.81B

P/E (TTM)

237.08x

Forward P/E (NTM)

75.08x

Forward P/S (NTM)

10.82x

Rev growth (TTM)

16.5%

YTD performance

5.8%

52W performance

15.3%

FCF yield

1.1%

TECHBio-Techne Corp

Market cap

$11.29B

P/E (TTM)

62.64x

Forward P/E (NTM)

34.64x

Forward P/S (NTM)

8.77x

Rev growth (TTM)

-0.4%

YTD performance

21.5%

52W performance

19.6%

FCF yield

2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RGEN

TECH

Detailed metrics comparison

RGEN

Repligen Corp

TECH

Bio-Techne Corp

Market Cap

RGEN$9.81B

TECH$11.29B

Enterprise Value

RGEN$9.76B

TECH$11.23B

Price

RGEN$173.88

TECH$72.46

P/E Ratio

RGEN237.08x

TECH62.64x

P/S Ratio

RGEN12.50x

TECH9.29x

EV/Sales

RGEN12.43x

TECH9.24x

EV/EBITDA

RGEN64.73x

TECH28.63x

P/B Ratio

RGEN4.86x

TECH5.39x

P/FCF Ratio

RGEN89.09x

TECH42.89x

EV/FCF

RGEN88.59x

TECH42.65x

PEG Ratio

RGEN11.27x

TECH9.81x

Forward P/E (NTM)

RGEN75.08x

TECH34.64x

Forward P/S (NTM)

RGEN10.82x

TECH8.77x

Revenue (TTM)

RGEN$785M

TECH$1.22B

Revenue Growth (YoY)

RGEN16.5%

TECH-0.4%

Forward Rev Growth

RGEN17.6%

TECH9.8%

Gross Margin (TTM)

RGEN53.8%

TECH66.2%

Operating Margin (TTM)

RGEN6.5%

TECH20.7%

EBITDA Margin (TTM)

RGEN18.8%

TECH31.6%

Net Margin (TTM)

RGEN5.3%

TECH15.0%

FCF Margin (TTM)

RGEN14.0%

TECH21.7%

Net Income (TTM)

RGEN$42M

TECH$182M

FCF (TTM)

RGEN$110M

TECH$263M

EPS (TTM)

RGEN$0.73

TECH$1.16

ROE (TTM)

RGEN2.0%

TECH8.9%

ROA (TTM)

RGEN1.4%

TECH7.1%

ROIC (TTM)

RGEN1.6%

TECH8.0%

Cash

RGEN$607M

TECH$265M

Debt

RGEN$551M

TECH$200M

Net Cash/Debt

RGEN$56M

TECH$65M

Current Ratio (TTM)

RGEN9.05x

TECH4.55x

Quick Ratio (TTM)

RGEN7.30x

TECH3.35x

Debt/Equity (TTM)

RGEN0.26x

TECH0.09x

Debt/Assets (TTM)

RGEN0.0%

TECH0.0%

Interest Coverage (TTM)

RGENN/A

TECHN/A

Net Debt/EBITDA (TTM)

RGEN0.00x

TECH0.00x

Beta

RGEN1.13

TECH1.29

52W Performance

RGEN15.3%

TECH19.6%

YTD Performance

RGEN5.8%

TECH21.5%

% from 52W High

RGEN-12.6%

TECH-0.3%

% from 52W Low

RGEN72.2%

TECH67.7%

Asset Turnover (TTM)

RGEN0.27x

TECH0.48x

FCF Yield (TTM)

RGEN1.1%

TECH2.3%

Earnings Yield (TTM)

RGEN0.4%

TECH1.6%

Dividend Yield (TTM)

RGENN/A

TECH0.4%

Rule of 40

RGEN30.5

TECH21.3

EV/GP/RG

RGEN1.46

TECH2.28

Ticker research

View RGEN research View TECH research

Metric	RGEN Repligen Corp	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$9.81B	$11.29B
Enterprise Value	$9.76B	$11.23B
Price	$173.88	$72.46
P/E Ratio	237.08x	62.64x
P/S Ratio	12.50x	9.29x
EV/Sales	12.43x	9.24x
EV/EBITDA	64.73x	28.63x
P/B Ratio	4.86x	5.39x
P/FCF Ratio	89.09x	42.89x
EV/FCF	88.59x	42.65x
PEG Ratio	11.27x	9.81x
Forward P/E (NTM)	75.08x	34.64x
Forward P/S (NTM)	10.82x	8.77x
Revenue & Growth
Revenue (TTM)	$785M	$1.22B
Revenue Growth (YoY)	16.5%	-0.4%
Forward Rev Growth	17.6%	9.8%
Profitability
Gross Margin (TTM)	53.8%	66.2%
Operating Margin (TTM)	6.5%	20.7%
EBITDA Margin (TTM)	18.8%	31.6%
Net Margin (TTM)	5.3%	15.0%
FCF Margin (TTM)	14.0%	21.7%
Net Income (TTM)	$42M	$182M
FCF (TTM)	$110M	$263M
EPS (TTM)	$0.73	$1.16
ROE (TTM)	2.0%	8.9%
ROA (TTM)	1.4%	7.1%
ROIC (TTM)	1.6%	8.0%
Financial Health
Cash	$607M	$265M
Debt	$551M	$200M
Net Cash/Debt	$56M	$65M
Current Ratio (TTM)	9.05x	4.55x
Quick Ratio (TTM)	7.30x	3.35x
Debt/Equity (TTM)	0.26x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.29
52W Performance	15.3%	19.6%
YTD Performance	5.8%	21.5%
% from 52W High	-12.6%	-0.3%
% from 52W Low	72.2%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.48x
FCF Yield (TTM)	1.1%	2.3%
Earnings Yield (TTM)	0.4%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	30.5	21.3
EV/GP/RG	1.46	2.28
Ticker research	View RGEN research	View TECH research

Valuation

P/E Ratio

TECH

62.64x

RGEN

237.08x

P/S Ratio

TECH

9.29x

RGEN

12.50x

EV/FCF

TECH

42.65x

RGEN

88.59x

Growth & revenue

Revenue Growth TTM

RGEN

16.5%

TECH

-0.4%

Forward Revenue Growth

RGEN

17.6%

TECH

9.8%

Profitability & performance

Gross Margin

TECH

66.2%

RGEN

53.8%

ROE

TECH

8.9%

RGEN

2.0%

FCF Yield %

TECH

2.3%

RGEN

1.1%

52-Week Performance

TECH

19.6%

RGEN

15.3%

Detailed metrics comparison

RGEN

Repligen Corp

TECH

Bio-Techne Corp

Market Cap

RGEN$9.81B

TECH$11.29B

Enterprise Value

RGEN$9.76B

TECH$11.23B

Price

RGEN$173.88

TECH$72.46

P/E Ratio

RGEN237.08x

TECH62.64x

P/S Ratio

RGEN12.50x

TECH9.29x

EV/Sales

RGEN12.43x

TECH9.24x

EV/EBITDA

RGEN64.73x

TECH28.63x

P/B Ratio

RGEN4.86x

TECH5.39x

P/FCF Ratio

RGEN89.09x

TECH42.89x

EV/FCF

RGEN88.59x

TECH42.65x

PEG Ratio

RGEN11.27x

TECH9.81x

Forward P/E (NTM)

RGEN75.08x

TECH34.64x

Forward P/S (NTM)

RGEN10.82x

TECH8.77x

Revenue (TTM)

RGEN$785M

TECH$1.22B

Revenue Growth (YoY)

RGEN16.5%

TECH-0.4%

Forward Rev Growth

RGEN17.6%

TECH9.8%

Gross Margin (TTM)

RGEN53.8%

TECH66.2%

Operating Margin (TTM)

RGEN6.5%

TECH20.7%

EBITDA Margin (TTM)

RGEN18.8%

TECH31.6%

Net Margin (TTM)

RGEN5.3%

TECH15.0%

FCF Margin (TTM)

RGEN14.0%

TECH21.7%

Net Income (TTM)

RGEN$42M

TECH$182M

FCF (TTM)

RGEN$110M

TECH$263M

EPS (TTM)

RGEN$0.73

TECH$1.16

ROE (TTM)

RGEN2.0%

TECH8.9%

ROA (TTM)

RGEN1.4%

TECH7.1%

ROIC (TTM)

RGEN1.6%

TECH8.0%

Cash

RGEN$607M

TECH$265M

Debt

RGEN$551M

TECH$200M

Net Cash/Debt

RGEN$56M

TECH$65M

Current Ratio (TTM)

RGEN9.05x

TECH4.55x

Quick Ratio (TTM)

RGEN7.30x

TECH3.35x

Debt/Equity (TTM)

RGEN0.26x

TECH0.09x

Debt/Assets (TTM)

RGEN0.0%

TECH0.0%

Interest Coverage (TTM)

RGENN/A

TECHN/A

Net Debt/EBITDA (TTM)

RGEN0.00x

TECH0.00x

Beta

RGEN1.13

TECH1.29

52W Performance

RGEN15.3%

TECH19.6%

YTD Performance

RGEN5.8%

TECH21.5%

% from 52W High

RGEN-12.6%

TECH-0.3%

% from 52W Low

RGEN72.2%

TECH67.7%

Asset Turnover (TTM)

RGEN0.27x

TECH0.48x

FCF Yield (TTM)

RGEN1.1%

TECH2.3%

Earnings Yield (TTM)

RGEN0.4%

TECH1.6%

Dividend Yield (TTM)

RGENN/A

TECH0.4%

Rule of 40

RGEN30.5

TECH21.3

EV/GP/RG

RGEN1.46

TECH2.28

Ticker research

View RGEN research View TECH research

Metric	RGEN Repligen Corp	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$9.81B	$11.29B
Enterprise Value	$9.76B	$11.23B
Price	$173.88	$72.46
P/E Ratio	237.08x	62.64x
P/S Ratio	12.50x	9.29x
EV/Sales	12.43x	9.24x
EV/EBITDA	64.73x	28.63x
P/B Ratio	4.86x	5.39x
P/FCF Ratio	89.09x	42.89x
EV/FCF	88.59x	42.65x
PEG Ratio	11.27x	9.81x
Forward P/E (NTM)	75.08x	34.64x
Forward P/S (NTM)	10.82x	8.77x
Revenue & Growth
Revenue (TTM)	$785M	$1.22B
Revenue Growth (YoY)	16.5%	-0.4%
Forward Rev Growth	17.6%	9.8%
Profitability
Gross Margin (TTM)	53.8%	66.2%
Operating Margin (TTM)	6.5%	20.7%
EBITDA Margin (TTM)	18.8%	31.6%
Net Margin (TTM)	5.3%	15.0%
FCF Margin (TTM)	14.0%	21.7%
Net Income (TTM)	$42M	$182M
FCF (TTM)	$110M	$263M
EPS (TTM)	$0.73	$1.16
ROE (TTM)	2.0%	8.9%
ROA (TTM)	1.4%	7.1%
ROIC (TTM)	1.6%	8.0%
Financial Health
Cash	$607M	$265M
Debt	$551M	$200M
Net Cash/Debt	$56M	$65M
Current Ratio (TTM)	9.05x	4.55x
Quick Ratio (TTM)	7.30x	3.35x
Debt/Equity (TTM)	0.26x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.29
52W Performance	15.3%	19.6%
YTD Performance	5.8%	21.5%
% from 52W High	-12.6%	-0.3%
% from 52W Low	72.2%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.48x
FCF Yield (TTM)	1.1%	2.3%
Earnings Yield (TTM)	0.4%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	30.5	21.3
EV/GP/RG	1.46	2.28
Ticker research	View RGEN research	View TECH research